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Active efﬂuxWecompared the P-glycoprotein ATPase activity in inside–out plasmamembrane vesicles and livingNIH-MDR1-
G185 cells with the aim to detect substrate transport. To this purpose we used six substrates which differ
signiﬁcantly in their passive inﬂux through the plasma membrane. In cells, the cytosolic membrane leaﬂet
harboring the substrate binding site of P-glycoprotein has to be approached bypassive diffusion through the lipid
membrane, whereas in inside–out plasma membrane vesicles, it is accessible directly from the aqueous phase.
Compounds exhibiting fast passive inﬂux compared to active efﬂux by P-glycoprotein induced similar ATPase
activity proﬁles in cells and inside–out plasmamembrane vesicles, because their concentrations in the cytosolic
leaﬂets were similar. Compounds exhibiting similar inﬂux as efﬂux induced in contrast different ATPase activity
proﬁles in cells and inside–out vesicles. Their concentrationwas signiﬁcantly lower in the cytosolic leaﬂet of cells
than in the cytosolic leaﬂet of inside-out membrane vesicles, indicating that P-glycoprotein could cope with
passive inﬂux. P-glycoprotein thus transported all compounds at a rate proportional to ATP hydrolysis (i.e. all
compounds were substrates). However, it prevented substrate entry into the cytosol only if passive inﬂux of
substrates across the lipid bilayer was in a similar range as active efﬂux.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
The ATP binding cassette transporter (ABC) P-glycoprotein (Pgp,
MDR1, ABCB1) is present in the plasma membrane of most cells.
Especially high expression levels are found in the apical membranes of
epithelial cells that play a role in absorption of exogenous compounds
(e.g. blood–brain barrier and intestinal barrier) or excretion of
metabolites (e.g. liver and kidney). The expression level is also high
in many tumor cells where Pgp contributes to multidrug resistance,
MDR (for review see [1]). It is known that Pgp binds its substrates in
the cytosolic membrane leaﬂet of apical membranes [2,3] and ﬂips
them back to the outer leaﬂet at the expense of ATP hydrolysis [4]. A
direct correlation between substrates transported and ATP molecules
hydrolyzed in inside–out plasma membrane vesicles or proteolipo-
somes has long been suggested [5–7]. However, this correlation is
rather difﬁcult to prove experimentally, since Pgp substrates are
generally electrically neutral or cationic (with intermediate or low
ionization constants, i.e. pKab9) and strongly accumulate in the lipid
membrane. If they are moreover small they diffuse rapidly through
the lipid membrane and escape partially to the cytosol before being
caught by Pgp in the cytosolic membrane leaﬂet, a phenomenon low.; ATP, adenosine triphosphate;
g resistance; Pgp, human P-
+41 61 267 21 89.
ll rights reserved.Dubbed the pump-leak mechanism by Stein [8] (see also (e.g. [9,10]).
Using spin labeled verapamil which carries a quaternary ammonium
ion and therefore cannot cross the lipid bilayer by passive diffusion
the correlation between ATPase activity and transport was demon-
strated convincingly [11]).
The direct correlation between Pgp ATPase activity and transport
was further demonstrated by assessing the net ﬂux of drugs across a
single membrane as the sum of active efﬂux by Pgp, V, (i.e. ATPase
activity) and passive inﬂux, ΦM, across the lipid bilayer. To this
purpose active efﬂux across the plasma membrane of NIH-MDR1-
G185 cells was measured and passive inﬂux, ΦM, across the lipid
bilayer was quantitatively estimated based on Fick's law, taking into
account the cross-sectional area of the diffusing molecule in its
membrane-bound conformation and the lateral packing density of the
lipid bilayer. The analysis revealed that compounds diffusing rapidly
across the cell membrane reach the cytosol despite being transported
by Pgp, whereas compounds diffusing slowly do not reach the cytosol
because Pgp can cope with their inﬂux. The latter compounds
corresponded to those which are considered as transported in bi-
directional transport assays [12,13].
Bi-directional transport assays are most commonly used to
investigate substrate transport by Pgp (see e.g. [14–16]). To this
purpose, polarized epithelial cells (e.g. MDCK or LLC-PK cells) are
cultured on a ﬁlter insert that separates an apical and a basolateral
compartment. This setup allows measurement of the net ﬂux of com-
pounds from the basolateral-to-apical and the apical-to-basolateral
side of conﬂuent cell monolayers. If the ﬂux of compounds in the
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efﬂux transporters are likely to be involved. The ﬂux from the
basolateral-to-apical side includes passive ﬂux across the entire cell,
ΦC, plus active export across the apicalmembrane, V, (ΦC+V), and the
ﬂux from the apical-to-basolateral side includes passive ﬂux across the
entire cell, ΦC, minus active transport across the apical membrane, V,
(ΦC−V), whereby the ﬂux ΦC is the product of the permeability
coefﬁcient, P, and the concentration gradient, ΔC (e.g. [13]). Com-
pounds with a positive ﬂux ratio (r=(ΦC+V)/(ΦC−V)N1) are
conventionally deﬁned as “substrates”. A positive ﬂux ratio in the
order of r≈1.2 to 11 is obtained if the passive ﬂux,ΦC, is ∼10 to ∼1.2-
fold faster than active efﬂux, V. Neither compounds exhibiting higher
passive inﬂux (more than 10 times higher than active efﬂux) nor
compounds exhibiting a lower passive inﬂux than efﬂux are
recognized as “substrates”, even though they may be transported by
Pgp. Passive inﬂux, ΦC, across the cell layer is generally assessed by
blocking Pgp with inhibitors such as verapamil or GF-120918 (see e.g.
[17]) that are cationic. At the high concentrations required for Pgp
inhibition, the compounds partition strongly into the lipid bilayer and
tend to impart a positive surface potential to the plasma membrane
[18], which in turn leads to reduced partitioning of further cationic
substrates. Passive inﬂux, ΦC, estimated by inhibiting Pgp in bi-
directional transport assays is therefore generally too low. A
quantitative interpretation of transport data at the molecular level is
complicated by the fact that drugs have to cross the entire cell layer,
and separation of active efﬂux, V, and passive inﬂux, ΦC, is difﬁcult.
The aim of the present study was to investigate transport across a
single membrane and to experimentally test the relation between
passive compound inﬂux, ΦM, and apparent compound efﬂux, V, by
Pgp. In cells, the cytosolic leaﬂet of the plasma membrane which
harbors the substrate binding site of Pgp has to be approached by
passive diffusion across the lipid bilayer, whereas in inside–out
plasma membrane vesicles it is accessible directly from the aqueous
phase. If passive inﬂux, ΦM, from the extracellular to the cytosolic
membrane leaﬂet is fast compared to active efﬂux, V, by Pgp, the drug
concentration in the cytosolic membrane leaﬂet should be similar in
cells and inside–out plasma membrane vesicles. Under these condi-
tions the ATPase activity, V, which directly reﬂects the drug
concentration in the cytosolic membrane leaﬂet [19] should also be
similar, as was indeed observed previously [20,21]. However, if
passive inﬂux, ΦM, across the membrane approaches active efﬂux, V,
by Pgp, the drug concentration in the cytosolic membrane leaﬂet
should be lower in cells than in inside–out membrane vesicles and the
Pgp ATPase activity proﬁles should no longer be identical. To test this
assumption, we measured the Pgp ATPase activity in cells and in
inside–out plasma membrane vesicles under steady-state conditions
by monitoring the substrate-induced extracellular acidiﬁcation rate,
ECAR, [21] and phosphate release rate [20], respectively. As
compounds we used three cationic drugs (verapamil, diltiazem and
daunorubicin) and three electrically neutral detergents (C12EO8,
Triton X-100 and Tween 80). The drugs [21] and the detergents [22]
all bind to Pgp but differ signiﬁcantly in their passive inﬂux, ΦM,
through the plasma membrane at their concentration of half-
maximum Pgp activity, K1. Passive inﬂux, ΦM, across the lipid bilayer
of the plasmamembrane was quantitatively estimated based on Fick's
law, using the data from surface activity measurements as described
previously [13].
The comparison of the ATPase activity in cells and inside–out
plasma membrane vesicles revealed that Pgp can establish a
concentration gradient between the cytosolic and extracellular
plasma membrane leaﬂet in cells (with a higher concentration in
the cytosolic leaﬂet) if passive substrate inﬂux,ΦM, approaches active
substrate efﬂux, V. However, no concentration gradient can be
established, despite the fact that the compounds are transported by
Pgp, if inﬂux is signiﬁcantly higher than efﬂux. The comparison of
ATPase activity proﬁles in cells, where diffusion occurs prior tobinding, and inside–outmembrane vesicles, where no diffusion step is
required, thus allows fast and convenient assessment of apparent
substrate transport by Pgp which neither system alone could provide.
2. Materials and methods
2.1. Compounds
The nonionic detergents C12EO8 (dodecyloctaglycerol), Triton
X-100, Tween 80 (polysorbate-80) and the cationic drugs dauno-
rubicin·HCl, diltiazem·HCl, (R/S)-verapamil·HCl were purchased
from Sigma-Aldrich (St. Louis, MO, USA).
2.2. Cell lines and cell culture
Mouse embryo ﬁbroblasts stably transfected with the human
MDR1 gene (NIH-MDR1-G185) [23] and the correspondingwild-type
cells (NIH-3T3) were a kind gift from Dr. M.M. Gottesman (National
Cancer Institute, Bethesda, U.S.A.). Cells were grown as monolayer
cultures in sterile cell culture ﬂasks (Costar, 25–75 cm2) and were
incubated at 37 °C in a Heraeus Incubator in an air atmosphere
supplemented with 5% CO2 and humidity saturation of 100%. As cell
culture medium, DMEM (containing 4.5 g/L glucose) was chosen,
supplemented with 1% L-glutamine (146 mg/L), streptomycin
(100 μg/mL), penicillin (100 U/mL) and 10% FBS (v/v). NIH-MDR1-
G185 cells were kept under growth selection with 0.15 μM
(60 ng/mL) colchicine. Passages (1:10) and (1:20) for NIH-MDR1-
G185 and NIH-3T3 cells, respectively, were performed twice a week,
from conﬂuent cultures, after treatment with trypsin–EDTA (Gibco).
Cellular stock aliquots of 107 cells/mL were prepared in DMEM, 10%
DMSO, 10% FBS and were kept in 1.8 mL Nunc CryoTubes frozen in
liquid nitrogen.
NIH-MDR1-G185 cells were characterized by means of FACS
analysis using the monoclonal, Pgp-speciﬁc antibody MRK16 and a
second ﬂuorescent FITC-labeled antibody. No wild-type contamina-
tion was observed [24]. The good agreement between the vinblastine-
and verapamil-stimulated Pgp ATPase activities measured by Ambud-
kar et al. [6] and Aanismaa et al. [20] suggested that the expression
level of Pgp in NIH-MDR1-G185 cells has remained approximately
constant over time.
2.3. Cytosensor measurements
Extracellular acidiﬁcation rates, ECARs, were monitored in real
time using an eight-channel Cytosensor® Microphysiometer (Molec-
ular Devices, Menlo Park, CA, U.S.A.) [25]. This device is based on
silicon technology and allows detection of pH changes down to 0.001
pH U/min by means of a light addressable potentiometric sensor,
LAPS. Protons excreted by cells upon stimulation come into contact
with the LAPS and induce a change in the applied voltage in the order
of a few μVolts s−1. According to the calibration, 61.0±1.1 mV
corresponds to 1 pH unit. The calibration of the instrument is
discussed in detail elsewhere [24].
Aliquots of (3–4)×105 cells were seeded into capsule cups (12-
mm-diameter plates with a microporous polycarbonate membrane
bottom) and were left in the incubator overnight for sedimentation
in the presence of the same medium used for culture, however,
without colchicine. For Cytosensormeasurements, capsule cupswere
transferred into the sensor chambers, adequately covered with
capsule spacers and inserts, in order to create a tight chamber of
2.8 μL. Thus, the actual number of cells available for themeasurement
was reduced to ∼1/4 of the total amount. The system was stabilized
at 37 °C and cells were superfused with DMEM without sodium
bicarbonate to limit pH buffering (100 μL/min). In order to preserve
the osmotic balance the lacking sodium bicarbonate was replaced by
sodium chloride (2.6 g/L NaCl instead of 3.7 g/L NaHCO3) in the case
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ﬂow medium was supplemented with 1 mM sodium pyruvate to
decrease the basal ECAR and to enhance the relative ECAR changes
due to Pgp activation [24].
The peristaltic pumps were programmed to function for 1 min
40 s, and then to stop for a period of 20 s, in a periodic cycle. During
the 20-s pause interval, acidic metabolites accumulated in the sensor
chamber. The ECAR recorded in μV s−1, started 5 s after pump stop
and lasted for 13 s. All data were directly processed by the software
Cytosoft for Macintosh (Molecular Devices, Menlo Park, CA, U.S.A.).
Before Pgp stimulation, cells were allowed to reach a stable ECAR
(30 min to 1 h). For stimulations, the normal running medium was
switched to the drug containing medium for 3 min. During this
period, two ECAR data points were recorded, one after 40 s
(transient situation) and the second 2 min later (steady-state
conditions established). For data analysis, the cellular ECAR change
corresponding to the second point was considered, normalized to
the basal activity, and therefore expressed in percentage of the basal
ECAR taken as 100%. The substrate concentration reaching the
measuring cell was corrected for adsorption to the Cytosensor tubing
in the case of drugs by means of spectroscopic measurements. An
analogous correction is not possible in the case of detergents. For
details see [21].
2.4. Plasma membrane preparation and ATPase measurements
The inside–out plasma vesicles were prepared as described in
detail elsewhere and exhibited a predominant inside–out orientation
[20]. The vesicles showed a rather broad size distribution with an
average diameter of approximately 1000 nm as determined with a
Zetasizer Nano, ZS. Due to the large diameter the lateral membrane
packing density in vesicles can be assumed to correspond approxi-
mately to that in cells. The ATPase activity wasmonitored bymeans of
a colorimetric phosphate release assay as described in detail
elsewhere [20]. Measurements were performed at pH 7.4 whereas
previous measurements were performed at pH 7.0.
2.5. Kinetic data evaluation
The Pgp ATPase activity measured as a function of the substrate
concentration generally yields bell-shaped proﬁles which are best
interpreted in terms of two-site binding models [26,27]. The model
proposed by Al-Shawi et al. [27] is based on non-competitive
inhibition and assumes that the transporter is blocked if the second
site is occupied, whereas the model proposed by Litman et al. [26] is
based on un-competitive or substrate inhibition and allows for
transport, although, at a reduced rate, even if the second binding
site is occupied (for details see [21]). Recent competition experiments
[22] support the latter model and suggest that the two binding sites
are juxtaposed [21,22].
We ﬁtted the bell-shaped activity curves with Eq. (1) [26]. The
model assumes transporter activation, if one substrate molecule is
bound to the transporter and inhibition if a second substrate molecule
is bound to the transporter as described by the following equation,
Vs =
K1K2V0 + K2V1CS + V2C
2
S
K1K2 + K2CS + C
2
S
ð1Þ
where V0 is the basal activity in the absence of substrates, V1 is the
maximum transporter activity (if only activation occurred), V2 is the
activity at inﬁnite substrate concentration, and CS is the substrate
concentration in aqueous solution. The kinetic parameters can be
obtained either by titrating Pgp with substrates in living cells or
inside–out plasma membrane vesicles, by monitoring the rate of
lactate release (i.e. ECAR) [21] or the rate of Pi release [20],
respectively.2.6. Surface activity measurements
Surface activity measurements were performed at room temper-
ature with the Wilhelmy vertical plate method, as described in detail
elsewhere [28,29]. Stock solutions were prepared in pure water and
serial aliquotswere injected bymeans of a Hamilton syringe into a 20-
or 3 -mL Teﬂon trough ﬁlled with buffer (50 mM Tris/HCl, containing
114 mM NaCl, pH 7.4 or pH 8.0) and the surface pressure, π, was
monitored as a function of time until equilibrium (i.e. a constant
surface pressure) was reached.
The thermodynamics of drug absorption at the air–water interface
is described by the Gibbs adsorption isotherm
dπ = RTCdlnC; ð2Þ
where π is the surface pressure, RT is the product of the gas constant
and the absolute temperature, C is the concentration of the
amphiphile in bulk solution in the monolayer trough and Γ is the
surface excess concentration of the amphiphile at the air–water
interface. The surface excess concentration can be expressed as
C = NAASð Þ−1 ð3Þ
where NA is the Avogadro number and AS the area requirement of the
molecule at the air–water interface. The surface excess concentration,
Γ, increases with increasing concentration up to a limiting value Γ∞.
The limiting value Γ∞was determined from the quasi-linear part of the
Gibbs adsorption isotherm,
C∞ = 1 = RTð Þdπ = dlnC: ð4Þ
Knowledge of the limiting surface concentration, Γ∞, allows
estimation of the limiting cross-sectional area of the molecule, AD,
in its amphiphilic orientation at the air–water interface (see Eq. (2)).
In the case of cationic drugs, the Gibbs adsorption isotherms were also
measured at pH 8.0 to minimize the charge repulsion effects and to
obtain the effective molecular cross-sectional area, AD, [30]. It can be
assumed that molecules inserted into the lipid–water interface adopt
the same amphiphilic orientation as in the air–water interface and
thus exhibit a similar cross-sectional area, AD, [31].
To evaluate the air–water partition coefﬁcient, Kaw, the Szyszkowski
equation,
π = RTC∞ln KawC + 1ð Þ ð5Þ
was used. The concentration, C, corresponds to the equilibrium
concentration of the drug, Ceq, in bulk solution that is deﬁned as the
total concentration, Ctot, minus the concentration of the drug
adsorbed to the air–water interface, Cb, [29]
Ceq = Ctot − Cb: ð6Þ
The concentration, Cb, is the product of the surface excess
concentration, Γ, and the surface area, A, per total volume, V of the
solution in the trough (Cb=Γ∞(A/V)). For small and intermediate air–
water partition coefﬁcients (Kawb106 M−1), the concentration
adsorbed to the air–water interface, Cb, is negligibly small (Ceq~Ctot).
In the present investigation, we corrected for the concentration, Cb,
since detergents exhibit rather large air–water partition coefﬁcients,
Kaw.
2.7. Estimation of lipid–water partition coefﬁcients
The lipid–water partition coefﬁcient, Klw, deﬁned as
Klw = Xb = Ceq; ð7Þ
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is the lipid concentration.
Xb = Cb = CL: ð8Þ
The lipid–water partition coefﬁcient, Klw, can be derived from the
air–water partition coefﬁcient, Kaw, if the cross-sectional area, AD, of
the drug and the lateral lipid packing density of the membrane, πM,
are known [30]
Klw = Kaw  e−πMAD =kT ; ð9Þ
where k is the Boltzmann constant and T the absolute temperature. If
the lipid membrane exhibits a surface potential, ψ, Eq. (9) can be
modiﬁed
Klw = Kaw  e−πMAD =kT  e−ψFz=RT ; ð10Þ
where F is the Faraday constant and z the charge of the molecule.
In the context of membrane permeation, the dimensionless lipid–
water partition coefﬁcient or mole fraction, γlw is generally used
γlw = Cm = Ceq; ð11Þ
where Cm is the concentration of drugs per liter lipid and Ceq the
concentration of free drug in solution. The two partition coefﬁcients,
Klw and γlw, are related as follows,
γlw = b  Klw; ð12Þ
where b has the dimension [mol/L]. If we assume for simplicity that
one mole of lipid corresponds approximately to one liter of lipid, the
factor is b≈1.
2.8. Estimation of permeability coefﬁcient, P, and the ﬂux, ΦM
The permeability coefﬁcient, P, is directly proportional to the
product of the lipid–water partition coefﬁcient, γlw, and the diffusion
coefﬁcient, D, of the drug and is inversely proportional to the
thickness of the membrane, Δx,
P = γlw  D=Δx: ð13Þ
The diffusion coefﬁcient, D, is, in turn, inversely related to the
radius, r, of the diffusing particle and the viscosity of the membrane,
η,
D = kT = 6πηrð Þ: ð14Þ
We used the radius, r, of the cross-sectional area, AD, of the
compounds. The ﬂux, Φ, is then deﬁned as the product of the
permeability coefﬁcient, P (Eq. (13)), and the concentration gradient,
ΔC, between the intracellular and extracellular environment. If only
the initial external aqueous concentration, C, is taken into account the
ﬂux can be expressed as,
ΦM = C  P: ð15Þ
In the case of charged compounds, it has to be considered that only
the fraction of compounds which is uncharged can cross the lipid
bilayer by passive diffusion as outlined in detail elsewhere [13].2.9. Estimation of the mole fraction of substrates in the cytosolic
membrane leaﬂet
The mole fraction of substrates, Xb, in the cytosolic membrane
leaﬂet of inside–out membrane vesicles at the concentration of half-maximum activation, Km, can be quantitatively estimated on the basis
of the Michaelis–Menten equation as shown previously [19]
VS = Vmax  CS = CS + Kmð Þ: ð16Þ
The steady-state concentration of substrates in aqueous solution
CS can be approximated by the equilibrium concentration, Ceq, and
can then be replaced by the quotient Xb/Klw (Eq. (7))
VS = Vmax  Xb = Xb + Km  Klwð Þ: ð17Þ
Half-maximum rate, Vmax/2, is reached if the mole fraction Xb
corresponds to the product Km·Klw. The mole fraction Xb of drugs in
the cytosolic membrane leaﬂet at the concentration of half-maximum
activation can thus be estimated as
Xb = Km  Klw: ð18Þ
For a given compound and a givenmembrane, the concentration of
half-maximum activation, K1 (Eq. (1)) and the concentration of half-
maximum activation, Km (Eq. (16)), are comparable. The mole frac-
tions given below correspond to Xb=K1·Klw.
3. Results
3.1. ECAR in MDR1-transfected cells measured as a function of time
We monitored the metabolic rate of living MDR1-transfected
mouse embryo ﬁbroblasts (NIH-MDR1-G185) and the corresponding
wild-type cells (NIH-3T3) by measuring the ECAR (μpH units) by
means of a Cytosensor microphysiometer [25]. The ECAR is essentially
due to the efﬂux of lactic acid produced as a waste product upon ATP
synthesis via glycolysis [24]. The ECAR induced by drugs or detergents
in NIH-MDR1-G185 cells directly corresponds to the rate of ATP
hydrolysis upon Pgp ATPase activation [20,21]. Fig. 1A–C show the
ECAR of MDR1-transfected (NIH-MDR1-G185) mouse embryo ﬁbro-
blasts and the corresponding wild-type (NIH-3T3) cells measured as a
function of time in cell culture medium. The ﬁrst data points in
Fig. 1A–C reﬂect the basal metabolic rate deﬁned as 100%. The
subsequent two data points correspond to the ECAR upon perfusion of
cells with verapamil (Fig. 1A), Triton X-100 (Fig. 1B) and Tween 80
(Fig. 1C) applied at an initial concentration, C=10 μM, to both NIH-
MDR1-G185 and NIH-3T3 cells, respectively. The modulation of the
drug- or detergent-induced ECAR was reported as percentage
variation of the basal rate. After stimulation for 3 min, during which
two data points were recorded, cells were re-perfused with drug- or
detergent-free medium until basal ECAR values were reached again
before a further stimulation cycle was started. As seen in Fig. 1A–C,
signiﬁcant changes were observed in MDR1-transfected cells due to
Pgp stimulation, but not in wild-type cells at the concentration used.
Higher concentrations of Triton X-100 and Tween 80 also induced a
metabolic change in wild-type cells. The ECAR changes in MDR1-
transfected cells induced by detergents and drugs could be inhibited
by cyclosporin A as shown below (Fig. 4A–C). This further demon-
strated that the ECAR changes were due to the activation of the Pgp
ATPase.
Verapamil and Triton X-100 (Fig. 1A and B) induced a maximum
ECAR of ∼170% and ∼160%, respectively, after 40 s. Upon re-perfusion
with detergent-free medium, basal values were reached again after
approximately 20 min for Verapamil and Triton X-100. Tween 80
(Fig. 1C) induced an ECAR of ∼135% after 40 s; however, the
maximum ECAR of ∼145% was reached only after re-perfusion with
detergent-free medium for ∼20 min, and basal values were reached
again after about 80 min. This suggests that the concentration of
10 μM was close to the concentration at which the maximum Pgp
ATPase activity of Tween 80 was reached and the second binding site
started to get occupied. Upon re-perfusion of cells with medium the
Fig. 1. (A–C) (A) Drug- and detergent-induced ECAR as a function of time. MDR1-
transfected mouse embryo ﬁbroblasts, NIH-MDR1-G185 (ﬁlled symbols), and wild-
typemouse embryo ﬁbroblasts, NIH-3T3 (open symbols). Stimulation by verapamil (A),
Triton X-100 (B) and Tween 80 (C) each compound was applied at an initial
concentration, C= 10 μM. Results are expressed as percent values of the basal ECAR
taken as 100%. Hatched and cross-hatched areas indicate the stimulation period of
3 min. The different time scales should be noted. Data are average values of n≈10
experiments.
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the second, inhibitory binding site was diluted, leading to increased
Pgp ATPase activity (for details, see Fig. 6 in ref. [21]). The relatively
slow efﬂux times observed after re-perfusion of the cells withmediumTable 1
Parameters obtained from ATPase activity and surface activity measurements, respectively.
Parameter Verapamil Diltiazem
pKa 8.9 ΔpKa 1.2 [18] 7.7 [43]
K1 (P) [M] 9.5×10−7 [18] 8.04×10−6
K2 (P) [M] 3.7×10−5 [18] 1.87×10−3
V1 (P) [%] 260 [18] 285
V2 (P) [%] 83 0
K1 (ECAR) [M] 5.0×10−7 [21] 3.5×10−6 [21]
K2 (ECAR) [M] 3.73×10−5 [21] 2.97×10−4 [21]
V1 (ECAR) [%] 160 [21] 180 [21]
V2 (ECAR) [%] 110 [21] 80 [21]
Xb at K1 (vesicles, cytosolic leaﬂet) 1.33×10−4 4.38×10−4
Kaw [M−1]d 1.66×105c 2.69×104
CMC [M] 5.0×10−3 1.0×10−2
AD [Å2] 82 [31] 70 [32]
Klw (from Kaw) [M−1]d 4.20×102 1.63×102
D [cm2s−1] 4.45×10−8 4.81×10−8
Φ at K1 [molecules s−1cm−2] 7.13×1015 2.54×1016
Φ at K1 [molecules s−1cm−2] 1.61×109 5.74×109
a For daunorubicin the concentration of half-maximum activity, K1, in inside–outmembran
The concentration of half-minimum activity, K2, could however be well determined, and th
b ECAR data were reevaluated according to the present new insights and differ from the
c Measured at pH 8.0.
d Kaw and Klw were determined at T= 25 °C. As discussed previously, values at T= 37 °Csuggested that drugs and detergents are continuously ﬂipped and
leave the membrane only slowly.
3.2. ECAR of NIH-MDR1-G185 cells as a function of substrate
concentration
As shown previously, the air–water partition coefﬁcient, Kaw, of
intrinsic Pgp substrates correlates reciprocally with the concentration
of half-maximum Pgp ATPase activity, K1 [32]. We therefore started
the titration of the Pgp ATPase with drugs or detergents somewhat
below the concentration, 1/Kaw, of the compounds and ended it close
to the critical micelle concentration, CMC (for data, see Table 1).
Fig. 2A–C show the Pgp ATPase activity as a function of the
concentration of the three drugs verapamil, diltiazem and daunoru-
bicin in NIH-MDR1-G185 cells at pH7.4 and T=37 °C. The ECAR was
expressed as percent of the basal extracellular acidiﬁcation rate taken
as 100%. The data points correspond to the second stimulation point
during the stimulation period of 3 min (see Fig. 1A–C) where a steady
state was reached. We also measured the ATPase activity as a function
of the drug concentration in inside–out plasma membrane vesicles
made from NIH-MDR1-G185 cells by monitoring the phosphate
release rate at pH 7.4 and T=37 °C and data were included in
Fig. 2A–C for comparison. The activity proﬁles obtained at pH 7.4 were
very similar to those obtained previously at pH 7.0 [20].
Fig. 2D–F show the same data as Fig. 2A–C; however, expressed as
drug-induced turnover number (i.e. after subtraction of the basal
activity). It should be noted that the basal ECAR in cells reﬂects the
total metabolism of the cell, including basal Pgp ATPase activity,
whereas the basal phosphate release rate in inside–out plasma
membrane vesicles reﬂects only the basal activity of the Pgp ATPase.
The turnover number was calculated using a basal activity,
V0=1.4×107 protons/cell/s and 1.95×106 Pgp molecules per cell
[6]. Verapamil (Fig. 2A, D) and Diltiazem (Fig. 2B, E) enhanced the Pgp
ATPase at low and reduced it at high concentrations, respectively,
yielding bell-shaped activity proﬁles in inside–out vesicles and cells.
Daunorubicin (Fig. 2C, F) inhibited the Pgp ATPase already at low
concentrations in inside–out plasma membrane vesicles but activated
it in cells.
Fig. 3A–F show the detergent-induced ATPase activity proﬁles in
cells and inside–out membrane vesicles [22]. The two detergents
C12EO8 and Triton X-100 (Fig. 3A, B) yielded bell-shaped activity
proﬁles, comparable to those observed in inside–out plasmaDaunorubicin Triton X-100 C12EO8 Tween 80
8.4 (basic)[35] 9.5 (acidic) – – –
6.8×10−7a 8.96×10−7 9.24×10−7 1.12×10−8
6.27×10−5 5.66×10−5 1.76×10−5 1.28×10−7
118 188 175 108
45 37 39 78
8.69×10−5b 3.00×10−6 1.30×10−6 4.50×10−5
n. d. 3.00×10−4 5.00×10−5 n. d.
14 168 263 154
n. d. 70 1 76 n. d.
1.59×10−5 1.43×10−2 3.57×10−2 1.04×10−3
5.89×105 3.34×106 7.30×106 1.30×108
0.6–3×10−4 0.23×10−3 0.095×10−3 0.01×10−3
106 [32] 73.2 71.9 99.3
2.59×102 1.60×104 3.87×104 9.29×104
3.91×10−8 4.7×10−8 4.75×10−8 4.04×10−8
7.5×1014 8.37×1016 1.98×1017 5.06×1013
1.70×108 7.57×1010 1.79×1011 7.32×108
e vesicles could not be evaluated with high accuracy due to the low Pgp ATPase activity.
e ratio K2/K1 seems reasonable compared to that of the other compounds.
previously published values [21].
are almost identical [22], all other constants were determined at 37 °C.
Fig. 2. (A–F) Pgp ATPase activity in NIH-MDR1-G185 cells (ﬁlled symbols) and inside–out plasma membrane vesicles (open symbols) induced by three drugs. (A–C) Pgp ATPase
activity expressed as percent of the basal value in the absence of drugs. (D–F) Pgp ATPase activity expressed as protons (i.e. lactic acid) or phosphate released per Pgp per second.
Calculations are based on the expression level of Pgp determined for NIH-MDR1-G185 by Ambudkar et al. [6]. (A, D) Verapamil (○,●); B, E: diltiazem (△,▲), and C, F: daunorubicin
(□, ■). Lines are ﬁts to Eq.(1). Standard deviations are shown.
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ATPase activity in cells and inhibited it in inside–out membrane
vesicles. The solid lines in Fig. 2A–F and Fig. 3A–F are ﬁts to the
modiﬁedMichaelis–Menten equation (Eq. (1)) [26], which is based on
un-competitive or substrate inhibition [21]. The kinetic constants
obtained from the ﬁts are summarized in Table 1.
A closer look at the Pgp ATPase activity proﬁles induced by Triton
X-100, C12EO8 and Tween 80 in inside-out plasma membrane
vesicles (Fig. 3A, B, C) shows that the activating branch decreases in
the order given. As shown previously the afﬁnity from water to the
transporter increases in the same order [22]. An analogous decrease in
activity with increasing substrate afﬁnity from water to the
transporter was observed previously for a larger set of compounds
(Fig. 7 in ref. [20]; and Fig. 10 in ref. [22]). It can be explained by the
high propensity of compounds with a high binding afﬁnity to the
transporter to occupy both binding sites already at very low aqueous
concentrations if added to inside–out vesicles. Reduced activity due to
high binding to the transporter was also observed for daunorubicin
(Fig. 2F). Interestingly, a similar daunorubicin ATPase activity proﬁle
was observed previously with Pgp reconstituted in Escherichia coli
lipids [33] which seem to exhibit a comparably high binding afﬁnity to
daunorubicin as the lipids in the plasma membrane of NIH-MDR1-
G185 cells.
3.3. Inhibition of the Pgp ATPase activity in MDR1-transfected cells by
cyclosporin A
Fig. 4 displays the Triton X-100-induced Pgp ATPase activity in the
presence of increasing concentrations of the Pgp inhibitor cyclosporin
A (0 μM(Fig. 4A), 1 μM(Fig. 4B) and 10 μM(Fig. 4C)). It shows that theTriton X-100-induced activity (8 μM) could be completely inhibited
with cyclosporin A in cells. Inhibition of Triton X-100-induced activity
was previously also shown in inside–out plasma membrane vesicles
[22]. The concentration required to inhibit the Triton X-100-induced
Pgp ATPase activity in Fig. 4C was however about seven-fold higher in
cells than in inside–out membrane vesicles [22].
3.4. Detergents applied above the critical micelle concentration in
living cells
The detergent-induced ATPase activity proﬁles (Fig. 3) were
measured well below the CMC, and the detergent-induced effects
were fully reversible. Fig. 5 shows the response of NIH-3T3 and NIH-
MDR1-G185 cells to a Triton X-100 concentration (C=0.3 mM)
slightly above the CMC (CMC=0.23 mM) applied for the same
period of time (3 min) as in the previous experiments below the
CMC. Above the CMC, Triton X-100 lead to a rapid and irreversible
ECAR decrease in both, wild-type and transfected cells which is due
to cell lysis. The Pgp ATPase was thus not able to protect the cells
from lysis by Triton X-100 applied above the CMC.
3.5. The air–water partition coefﬁcient and the cross-sectional area
of substrates
Drugs and detergents were characterized by means of surface
activity measurements. The air–water partition coefﬁcients, Kaw, of
the cationic drugs weremeasured previously at pH 7.4 and pH 8.0 (see
references in Table 1). The higher pH value was used to minimize
charge repulsion effects for the determination of molecular cross-
sectional areas. Here wemeasured the surface pressure, π, of the three
Fig. 4. (A–C) Inhibition of Triton X-100-induced ECAR by cyclosporin A. ECAR
modulations in NIH-MDR1-G185 (●, ■) and NIH-3T3 (△) cells are shown, after
3 min exposure to 8 μM Triton X-100 alone (A), and in the presence of 1 μM (B) and
10 μM (C) cyclosporin A, respectively. The Triton X-100 and cyclosporin A
concentrations were not corrected for adsorption.
Fig. 3. (A–F) Pgp ATPase activity in NIH-MDR1-G185 cells (ﬁlled symbols) and inside–out plasmamembrane vesicles (open symbols) induced by three detergents. (A–C) Pgp ATPase
activity expressed as percent of the basal value in the absence of drugs. (D–F) Pgp ATPase activity expressed as protons (i.e. lactic acid) or phosphate released per Pgp per second.
Calculations are based on the expression level of Pgp determined for NIH-MDR1-G185 by Ambudkar et al. [6]. (A, D) Triton X-100 (○, ●); (B, E) C12EO8 (△, ▲) and C, F: Tween
80 (□, ■). Lines are ﬁts to the Eq.(1). Standard deviations are shown.
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equilibrium surface pressure was reached after about 15 min in the
case of Triton X-100 and C12EO8 and after more than 60 min in the
case of Tween 80 (not shown) and was then plotted as a function of
concentration (Gibbs adsorption isotherms). At low concentrations
the surface pressure, π, increased slowly, then reached a constant
slope up to the critical micelle concentration, CMC, from where the
surface pressure increased no longer (not shown) (analogous
measurements are described elsewhere in detail [29]). From the
linear slope of the π/logC plot, the surface excess concentration, Γ∞,
(see Eq. (4)) and the cross-sectional area, AD, of the molecule in its
amphiphilic orientation at the air–water interface (see Eq. (3)) were
derived. The air–water partition coefﬁcient, Kaw, was then evaluated
by ﬁtting the data to Eq. (5). The cross-sectional area, AD, of Triton X-
100, C12EO8 and Tween 80 were determined as 73.2, 71.9 and 99.3 2,
respectively, at pH 7.4. The data obtained from surface activity
measurements are summarized in Table 1.
3.6. Estimation of the lipid–water partition coefﬁcient of substrates
Knowledge of the cross-sectional area, AD, and the air–water
partition coefﬁcient, Kaw, allows estimation of the lipid–water
partition coefﬁcient, Klw, according to Eq. (9) for an electrically
neutral membrane with a speciﬁc lateral packing density, πM. For
electrically neutral compounds and weak bases, an excellent
prediction is obtained using the air–water partition coefﬁcient, Kaw,
determined at pH 7.4. For highly charged compounds such as
verapamil, the prediction is better if the air–water partition
coefﬁcient, Kaw, is determined at pH 8.0 [29]. The lateral packing
density of the plasma membrane of NIH-MDR1-G185 cells was
previously estimated as πM=30 mN/m [21]. Lipid–water partitioncoefﬁcients for drugs and detergents determined according to Eq. (9)
are summarized in Table 1. The values are slightly higher than those
measured for large unilamellar vesicles, LUVs, formed by 1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphocholine, POPC [22] exhibiting a lateral
packing density of πM=32 mN/m [34].
NIH-MDR1-G185 cells and the corresponding inside–out plasma
membrane vesicles showed a negative zeta potential in buffer
solution containing magnesium chloride (ζ=−25 mV) (see footnote
1 in Ref. [21]). In cells, the negative zeta potential arises from the
glycocalix which may accumulate cationic drug in the vicinity of the
electrically neutral lipid membrane surface. In inside–out vesicles,
negative zeta potential arises from the negatively charged lipids in the
cytosolic membrane leaﬂet. Provided the lipid asymmetry is
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zeta potential), is adequate and yields lipid–water partition coefﬁ-
cients, Klw, which are higher bymaximally a factor of two for the three
cationic drugs (not shown). For the following discussion, we assumed
to a ﬁrst approximation that the two plasma membrane leaﬂets
exhibit the same lipid–water partition coefﬁcients.
3.7. Estimation of permeability coefﬁcient, P, and passive substrate
inﬂux, ΦM
The permeability coefﬁcient, P, and the ﬂux, ΦM, of drugs and
detergents at their concentration of half-maximum activation, K1,
were calculated according to Eqs. (13) and (15) using the air–water
partition coefﬁcient, Kaw, and the cross-sectional area, AD, determined
by surface activity measurements (see Table 1), the lateral packing
density of the mouse embryo plasma membrane, estimated as
πM=30 mN/m [21], and a membrane viscosity, η=1 poise. In the
case of drugs, we took into account that only the fraction of uncharged
drugs can permeate the membrane. The pKa values used for
calculations are included in Table 1 (for details see [13]).
The inﬂux of verapamil, diltiazem and daunorubicin at the
respective concentrations of half-maximum activation, K1, was
calculated as ΦM ∼7.13·1015, ΦM ∼2.54·1016 and ΦM ∼7.5·1014
molecules·s−1·cm−2, respectively. For daunorubicin, experimentally
determined values for the ﬂux, ΦM, across lipid bilayers are available
[35], which allowed testing the present approach. Frézard and Garnier
[35] measured the ﬂux, ΦM, of daunorubicin at a concentration,
C= 1 μM across DNA-containing negatively charged lipid vesicles of
different composition at pH 6.0 and a temperature, T=37 °C. With a
lipid mixture of phosphatidylcholine/phosphatidic acid/cholesterol
(60/20/20), respectively, the ﬂux was determined experimentally as
approximately ΦM ∼2 1015 molecules s−1 cm−2. Taking into account
a negative surface potential of ψ=− 30 mV and a lateral membrane
packing density of πM=30 mN/m, we calculated the ﬂux at pH 6.0
according to Eq. (13) as ΦM ∼1.5×1014 molecules s−1 cm−2.
Considering that daunorubicin was dissolved in the presence of
Triton X-100 (presumably to prevent self-association) which
enhances permeation, and that the lipid/DNA ratio was most likely
higher than in cells which may further enhance inﬂux, the calculated
value can thus be considered as reasonable estimate.
Permeability coefﬁcients of the detergents calculated according to
Eq. (13) are likely to be somewhat overestimated for the followingFig. 5. Cell lysis upon addition of detergent above the CMC. Exposure of NIH-MDR1-
G185 (■,●) and NIH-3T3 cells to 0.3 mM Triton X-100 during a period of 3 min (area
outlined). ECAR modulations are expressed as percent of the basal value in the absence
of drugs, which is arbitrarily deﬁned as 100%.reasons. Diffusion of the polyethoxylated and hydroxylated head
groups may be more unfavorable than estimated on the basis of lipid–
water partition coefﬁcients. Upon insertion into a lipid layer the
hydroxyl groups of detergents may remain fully or partially exposed
to the aqueous phase, whereas upon diffusion or ﬂip-ﬂop the hydroxyl
groups have to cross the hydrocarbon-like, hydrophobic core of the
membrane. Comparing the partitioning of cyclohexane and cyclohex-
anol Wolfenden and Liang determined the standard free energy of
transfer of a hydroxyl group (−OH), ΔG−OH0 , from water to
cyclohexane as ΔG−OH0 =23 kJ/mol [36]. Using dodecyl methyl
pentaerythrityl ethers, the standard free energy of transfer of a
hydroxyl group from a less polar (hexane/chloroform) to the more
polar phase (ethanol/water) was determined as ΔG−OH0 =− 559 cal/
mol (−2.24 kJ/mol) [37]. To estimate the inﬂuence of a hydroxyl
group upon transfer of the detergent head groups to the hydrophobic
core region of the membrane, the standard free energy of transfer
ΔG−OH0 was translated into a partition coefﬁcient per hydroxyl group
according to the following equation
ΔG0−OH = − RT lnK−OH; ð19Þ
yielding a value of K−OH=0.0001 [36] and K−OH=0.4 [37]. The latter
solvent mixtures seem to be more adequate to the present situation
and therefore the permeability coefﬁcients, P, (Eq. (13)) of detergents
weremultiplied by a factor of 0.4 per hydroxyl group. Theﬂux of Triton
X-100, C12EO8 and Tween 80 at the respective concentrations of half-
maximum activation, K1, was roughly estimated as ΦM ∼8.37×1016,
ΦM ∼1.98×1017 and ΦM ∼5.06×1013 molecules·s−1×cm−2, respec-
tively. Considering the abovediscussion, the value given in Table 1may
be upper limits.
The cross-sectional area, AD, of the molecule is a further parameter
of relevance for passive inﬂux. The area requirement of C12EOn
molecules (n=1–8) in a liquid crystalline lipid bilayer was estimated
previously by resonance energy transfer between the ﬂuorescent
probe molecules NBD-PE and rhodamine-PE [38]. For C12EO8 in a
POPC bilayer, this yielded an area requirement of A=116 Å2 (see
[38]). By X-ray diffraction, the cross-sectional area of C12EO8 was
assessed as A=66 Å2, which is much closer to the value obtained from
the Gibbs adsorption isotherm (AD=71.9 Å2).
4. Discussion
4.1. Substrate transport by Pgp
We measured the ATPase activity in NIH-MDR1-G185 cells and in
the corresponding inside–out plasma membrane vesicles under
steady-state conditions. Since the lipid bilayer of the plasma
membrane highly accumulates the drugs [21], the processes observed,
i.e. active substrate efﬂux by Pgp, V, and passive substrate inﬂux, ΦM,
can be conﬁned to the plasmamembrane. The comparison of cells and
inside–out plasma membrane vesicles can thus be considered as
comparison of right side-out with inside–out plasma membranes as
illustrated in Fig. 6, at least to a ﬁrst approximation. Active efﬂux
stands for the number of substrates moved from the cytosolic
membrane leaﬂet to the extracellular leaﬂet per time and area, and
passive inﬂux stands for the number of molecules moved from the
extracellular to the cytosolic membrane leaﬂet per time and area.
Thereby, it has to be noted that active efﬂux is preceded by a diffusion
step in cells but not in inside–out membrane vesicles. This difference
is exploited to test the inﬂuence of diffusion on the ability of Pgp to
protect the cells from intruding drugs and toxins. Calculations of
passive inﬂux across the lipid bilayer were used to verify data
interpretation, but are not required per se to diagnose transport using
ATPase assays as will be discussed in more detail below.
The two drugs verapamil and diltiazem (Fig. 2A, B, D, E) induced
bell-shaped Pgp ATPase activity curves, in cells and inside–out plasma
Fig. 6. (A–D) Drug access to the Pgp binding site in cells and inside–out vesicles. In cells, the drug has to diffuse across the lipid bilayer (A, C) to access the cytosolic membrane leaﬂet
which harbors the substrate binding site of Pgp. In inside–out plasma membrane vesicles (B, D), it can directly access the cytosolic leaﬂet from the aqueous phase. The extracellular
and the cytosolic membrane leaﬂets are indicated as gray and hatched, horizontal rectangles, respectively. Pgp is represented as vertical rectangle with two circles attached,
representing the nucleotide binding domains. The black ovals indicate the compounds applied. (A and B) Compounds applied equilibrate rapidly (large arrow) between the two
leaﬂets compared to efﬂux (smaller arrow). (C and D) Compounds equilibrate with similar rate compared to efﬂux (similar length of arrows). Under these conditions, Pgp is able to
establish a concentration gradient.
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concentrations of half-maximum, K1, and half-minimum, K2, Pgp
ATPase activity, respectively (see Table 1), were similar in the two
systems suggesting that the mole fractions, Xb, of the two drugs in the
cytosolic leaﬂet of cells and inside–out plasma membrane vesicles
were also similar. The mole fraction, Xb, of drugs in the cytosolic
membrane leaﬂet of inside–out membrane vesicles was estimated
according to Eq. (18) (Table 1). This implies that the two drugs
equilibrated rapidly between the cytosolic and extracellular leaﬂet of
the plasma membrane in both systems. Passive inﬂux of verapamil
and diltiazem at their concentration of half-maximum activation, K1,
was determined as ΦM=1.61×109 molecules s−1 cell−1 and
ΦM=5.74×109 molecules s−1 cell−1 respectively, which is indeed
more than one order of magnitude higher than active efﬂux by Pgp
determined previously as V=107–108 molecules s−1 cell−1 [20]. The
situation of compounds equilibrating rapidly between the two
membrane leaﬂets compared to the rate of transport by Pgp is
illustrated schematically for cells (Fig. 6A) and inside–out membrane
vesicles (Fig. 6B).
Titration of the Pgp ATPase with daunorubicin yielded in contrast
signiﬁcantly different activity proﬁles in cells and inside–out
membrane vesicles (Fig. 2C, F). In cells, only the activating branch of
the Pgp ATPase activity proﬁle was observed (K1=8.69×10−5 M),
suggesting that the concentration (or mole fraction) of daunorubicin
in the cytosolic membrane leaﬂet was relatively low and only one Pgp
binding site was occupied by the drug. In inside–out plasma
membrane vesicles, the inhibitory branch was predominant
(K2=6.27×10−5 M), suggesting that the concentration in the
cytosolic membrane leaﬂet was signiﬁcantly higher and both Pgp
binding sites were occupied by daunorubicin.
The daunorubicin-induced concentration of half-maximum acti-
vity in inside–out membrane vesicles was determined as K1=6.8×
10−7 M. It seems reasonable to assume that the mole fraction in the
cytosolic leaﬂet required to elicit a given response is identical in cellsand inside–out membrane vesicles. The aqueous daunorubicin
concentration required to elicit half-maximum activity in cells was
much higher (K1=8.69×10−5 M). Assuming identical binding
constants for the two membrane leaﬂets and a linear increase with
the aqueous concentration of daunorubicin, the mole fraction of
daunorubicin in the extracellular leaﬂet of cells should be approxi-
mately two orders of magnitude higher (as derived from the ratio K1
(cell)/K1 (vesicle)=127). This value may be somewhat overesti-
mated since the increase in binding is no longer linear at high
daunorubicin concentrations. For daunorubicin, the mole fraction
ratio between the extracellular and the cytosolic leaﬂet in cells is
therefore estimated as Xb≤127. The concentration gradient observed
suggests that Pgpwas able to copewith the low inﬂux of daunorubicin
(ΦM=1.7·108 molecules s−1 cell−1). The situation of compounds
equilibrating slowly between the twomembrane leaﬂets compared to
the rate of transport by Pgp is illustrated in Fig. 6C, D.
In the case of detergents, analogous observations were made. The
more rapidly diffusing compounds Triton X-100 (ΦM=7.57×1010
molecules s−1 cell−1) and C12EO8 (ΦM=1.79×1011 molecules s−1
cell−1) induced similar bell-shaped Pgp ATPase activity proﬁles in
inside–out membrane vesicles and cells, suggesting similar detergent
concentrations in the cytosolic leaﬂet of the lipid membrane
independent of the side of application. The small shift of the
concentration of half-maximum activation, K1, to higher values and
the concomitant stronger activation in cells compared to inside–out
membrane vesicles is due to a reduced concentration of detergents in
the cytosolic leaﬂet, either because of a lower passive ﬂux (see section
3.7) than given above or because of a slight absorption of detergents
to the tubing of the Cytosensor.
The more slowly diffusing Tween 80 (ΦM=7.32×108 molecules
s−1 cell−1) showed only the activating branch of the activity proﬁle in
cells and a predominant inhibitory branch in inside–out membrane
vesicles (Fig. 3C, D). For Tween 80, themole fraction ratio between the
extracellular and the cytosolic membrane leaﬂet was more than an
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an even lower passive inﬂux of Tween 80 than given in Table 1 (see
section 3.7).
The analysis shows that high substrate concentrations in the
extracellular leaﬂet of living cells (i.e. in the off-side of the Pgp
ATPase) did not inhibit substrate unloading by Pgp as suggested
previously based on experiments with inside–out membrane vesicles
which exhibit a limited intra-vesicular space (see e.g. [11,39,40]).
4.2. Consequences for drug therapy
The present and previous [22] experiments revealed that it is
relatively easy to reduce or inhibit the Pgp ATPase activity in inside–
out membrane vesicles since molecules have direct access to the
cytosolic leaﬂet membrane leaﬂet which harbors the Pgp binding site
[12]. The most efﬁcient inhibitors are hydrophobic compounds with a
high lipid–water partition coefﬁcient and/or compounds with a high
afﬁnity to the transporter in the lipid membrane [12,21] that occupy
the second binding site of Pgp already at low aqueous concentrations.
In excretory systems (liver and kidney), drugs or metabolites
approach the apical membrane and Pgp from the basolateral side
(i.e. from the same side as in inside–out plasma membrane vesicles).
Pgp inhibition is thus facilitated and may contribute to cholestatic
liver diseases.
In absorptive systems (blood–brain barrier, intestinal barrier and
also in cancers), drugs or metabolites approach the apical membrane
from the apical side. Binding to Pgp is therefore preceded by a passive
diffusion step as in the cellular assay. The present experiments show
that it is difﬁcult to inhibit Pgp in cells because compounds bind to the
extracellular membrane and reach the cytosolic membrane leaﬂet by
passive diffusion across the lipid bilayer before binding to Pgp. Due to
the “upstream” diffusion process Pgp gets the opportunity to cope
with low substrate inﬂux. Many Pgp inhibitors have low inﬂux (i.e. a
low product of the diffusion coefﬁcient and concentration gradient)
which reduces their concentration in the cytosolic membrane leaﬂet,
prevents occupation of the second binding site of Pgp and in turn
inhibition. It should be noted that in cells a ten times higher
cyclosporin A concentration was required to inhibit Pgp (Fig. 4)
than in inside–out vesicles [22]. The present results at least partially
explain why Pgp inhibition in absorptive systems has so far not been
as successful in clinical trials as expected on the basis of in vitro
inhibition experiments [41].
As discussed elsewhere in detail [13], the active efﬂux, V, depends
on the expression level of Pgp and only to a small extent on the lateral
membrane packing density of the membrane [42]. Passive inﬂux, in
contrast, strongly (exponentially) depends on the lateral packing
density of the membrane. It efﬁciently reduces passive inﬂux which
gives Pgp the chance to cope. Membranes with a high lateral packing
density such as the BBB are therefore excellent barriers.
In summary, the different substrate pathways in living cells and
inside–out plasma membrane vesicles to the Pgp binding site in the
cytosolic membrane leaﬂet were exploited to monitor substrate
transport by Pgp at themolecular level. The experiments revealed that
export from the cytosolic leaﬂet back to the extracellular leaﬂet
prevents substrate inﬂux into the cytosol, provided that compounds
diffuse slowly and do not disrupt the lipid bilayer. If inﬂux of drugs or
toxin is more than ten-fold higher than active efﬂux, the Pgp ATPase
can no longer cope efﬁciently. Active efﬂux which is proportional to
the rate of ATP hydrolysis varied by less than a factor of 10, whereas
passive inﬂux calculated at the concentration of half-maximum
activity, K1, varied by about three orders of magnitude for the
different compounds. Passive inﬂux is thus the dominant factor. If Pgp
can cope with inﬂux, a concentration gradient is established across
the plasma membrane of cells (with a lower concentration in the
cytosolic leaﬂet) which can be roughly quantiﬁed based on simple
thermodynamic and kinetic principles. Whereas bi-directional trans-port assays reveal the net ﬂux of compounds, measurement of
substrate-induced P-glycoprotein ATPase activity in living MDR1-
transfected cells and inside–out plasma membrane vesicles per-
formed in parallel yields direct insights into substrate transport at the
molecular level.
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